Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.

Gillis AM, Kerr CR, Philippon F, Newton G, Talajic M, Froeschl M, Froeschl S, Swiggum E, Yetisir E, Wells GA, Tang AS.

Circulation. 2014 May 20;129(20):2021-30. doi: 10.1161/CIRCULATIONAHA.112.000417. Epub 2014 Mar 7.

2.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators.

N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.

3.

Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer.

Froeschl S, Nicholas G, Gallant V, Laurie SA.

J Thorac Oncol. 2008 Feb;3(2):163-9. doi: 10.1097/JTO.0b013e318160c0cb.

Supplemental Content

Loading ...
Support Center